Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals

• US 5,772,999 A
• Filed: 07/30/1996
• Issued: 06/30/1998
• Est. Priority Date: 07/30/1996
• Status: Expired due to Term

• Current Assignee: Arkion Life Sciences
• Original Assignee: DCV Biologics L.P.
• Inventors: Brodie, David Alan, Adalsteinsson, Orn, Greenblatt, Hellen Chaya, Fitzpatrick-McElligott, Sandra G.
• Primary Examiner(s): Saucier, Sandra E.
• Application Number:
  US08/688,576
• Time in Patent Office: 700 Days
• Field of Search: 424/157.1, 424/158.1
• US Class Current: 424/157.1
• CPC Class Codes: A61K 2039/55588 Adjuvants of undefined constitution
• CPC Class Codes: A61K 35/20 Milk; Whey; Colostrum
• CPC Class Codes: A61K 35/57 Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
• CPC Class Codes: A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system
• CPC Class Codes: A61P 1/04 for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
• CPC Class Codes: A61P 31/04 Antibacterial agents
• CPC Class Codes: A61P 31/12 Antivirals

Abstract

A method of preventing, countering or reducing chronic gastrointestinal disorders or NSAID-induced gastrointestinal damage in a subject suffering from such ailments. The method comprises hyperimmunizing an egg-producing and/or milk-producing animal and administering an effective amount of hyperimmunized egg product, hyperimmunized milk product or mixtures thereof to the subject.

Claims

1. A method for preventing or reducing non-steroidal, anti-inflammatory drug-induced gastrointestinal damage in a subject who will receive or is receiving a non-steroidal, anti-inflammatory drug, comprising the steps of:

hyperimmunizing an egg-producing animal or a milk-producing animal;

collecting hyperimmunized egg product or hyperimmunized milk product from the hyperimmunized animal;

administering the egg or milk product to the subject, wherein the egg or milk product is capable of preventing or reducing said gastrointestinal damage, in an amount sufficient to prevent or reduce said gastrointestinal damage; and

administering a non-steroidal, anti-inflammatory drug.

2. The method of claim 1 wherein the subject is administered an effective amount of hyperimmunized egg product.

3. The method of claim 1 wherein the subject is administered an effective amount of hyperimmunized milk product.

4. The method of claim 1 wherein the subject is separately administered an effective amount of hyperimmunized egg product and hyperimmunized milk product.

5. The method of claim 1 wherein the subject is administered a composition comprising an effective amount of hyperimmunized egg product and hyperimmunized milk product.

6. The method of claim 1 wherein the egg-producing animal or milk-producing animal is hyperimmunized with an antigenic or genetic vaccine.

7. The method of claim 6 wherein the antigenic vaccine comprises at least one antigen selected from the group consisting of bacterial, viral, protozoan, fungal, and cellular antigens and combinations thereof.

8. The method of claim 6 wherein the genetic vaccine comprises at least one antigen coding DNA construct selected from the group consisting of fragments of naked DNA, plasmid DNA, viral DNA, bacterial DNA, DNA expression libraries, DNA-RNA antigens, DNA-protein conjugates and DNA liposome conjugates, and combinations thereof.

9. The method of claim 1 wherein the egg-producing animal is a member of the avian class.

10. The method of claim 9 wherein the egg-producing animal is selected from the group consisting of fowl, turkey, duck, and goose.

11. The method of claim 1 wherein the milk-producing animal is a member of the bovid class.

12. The method of claim 11 wherein the milk-producing animal is selected from the group consisting of cow, goat, sheep, buffalo, and llama.

13. The method of claim 6 wherein the antigenic vaccine is a killed vaccine.

14. The method of claim 6 wherein the antigenic vaccine is a live-attenuated vaccine.